ALKS FY 2016 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena

ALKSAlkermes plc

$5B

FY 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$746M+18.7% YoY

Gross Profit

$614M82.3% margin

Operating Income

-$209M-28.0% margin

Net Income

-$208M-28.0% margin

EPS (Diluted)

$-1.38

Cash Flow

Operating Cash Flow

-$64M

Free Cash Flow

-$107M

Stock-Based Comp.

$94M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$517M

Stockholders' Equity

$1.2B

Cash & Equivalents

$186M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$746M	$628M	+18.7%
Gross Profit	$614M	$489M	+25.4%
Operating Income	-$209M	-$224M	+7.0%
Net Income	-$208M	-$227M	+8.2%